Biofrontera Inc.
Biofrontera Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 6 | 6 | 3 | 7 | 2 | 6 | 3 | 4 | 4 | 1 | 3 | 4 | |||||
Equity Securities Fv Ni | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | 6 | |||||
Accounts Receivable Net | 4 | 7 | 3 | 4 | 4 | 5 | 5 | 4 | 4 | 5 | 4 | 2 | |||||
Inventory Net | 1 | 1 | 4 | 4 | 7 | 7 | 7 | 4 | 7 | 11 | 16 | 15 | |||||
Prepaid Expense And Other Assets Current | 1 | 2 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | - | - | 2 | 2 | 2 | 2 | 2 | - | - | - | - | - | |||||
Assets Current | 13 | 18 | 14 | 19 | 15 | 21 | 17 | 17 | 20 | 23 | 30 | 32 | |||||
Inventory Noncurrent | 4 | 4 | - | - | - | - | - | - | - | - | - | - | |||||
Property Plant And Equipment Net | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 3 | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | |||||
Intangible Assets Net Excluding Goodwill | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 3 | 3 | 3 | |||||
Other Assets | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Assets | 25 | 29 | 15 | 20 | 17 | 22 | 19 | 22 | 25 | 28 | 34 | 37 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | - | - | - | 7 | 7 | |||||
Operating Lease Liability Current | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 5 | 5 | 7 | 6 | 5 | 4 | 5 | 4 | 4 | 4 | 11 | 11 | |||||
Lines Of Credit Current | - | - | - | - | - | - | - | - | - | - | 2 | 1 | |||||
Short Term Borrowings | - | - | - | - | - | - | - | 0 | 2 | 4 | - | - | |||||
Liabilities Current | 11 | 12 | 13 | 20 | 11 | 12 | 11 | 9 | 14 | 18 | 29 | 25 | |||||
Liabilities Noncurrent | |||||||||||||||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | - | - | - | 3 | 2 | |||||
Convertible Notes Payable | 5 | 5 | 4 | 4 | 4 | 4 | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 19 | 18 | 18 | 25 | 16 | 18 | 13 | 11 | 26 | 23 | 33 | 30 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 139 | 138 | 131 | 122 | 122 | 122 | 122 | 121 | 105 | 104 | 104 | 104 | |||||
Retained Earnings Accumulated Deficit | -133 | -128 | -134 | -127 | -122 | -117 | -116 | -110 | -110 | -100 | -103 | -97 | |||||
Stockholders Equity | 6 | 10 | -3 | -5 | 0 | 4 | 6 | 11 | -5 | 5 | 1 | 7 | |||||
Liabilities And Stockholders Equity | 25 | 29 | 15 | 20 | 17 | 22 | 19 | 22 | 25 | 28 | 34 | 37 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | - | 0.001 | - | - | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | - | 20 | - | - | 20 | 20 | 20 | 20 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 315 | 315 | 315 | 300 | 300 | |||||
Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | 47 | 47 | 47 | 51 | 53 | 53 | 52 | 51 | 51 | 55 | 55 | 55 | |||||
Shares Outstanding | 47 | 47 | 47 | 51 | 53 | 53 | 52 | 51 | 51 | 55 | 55 | 55 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.46% | 2.12% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -14.29% | 0.00% | 48.57% | -11.16% | 12.63% | 15.79% | -14.17% | -25.56% | -4.52% | 20.33% | 34.35% | 9.23% |
| 2024 | -18.18% | -31.82% | -9.09% | -2.63% | -15.79% | -4.39% | 41.84% | 58.87% | 60.28% | -18.45% | -32.52% | -41.75% |
| 2023 | - | - | - | -17.58% | -15.27% | -64.73% | -4.09% | -29.16% | -61.38% | 16.77% | 10.97% | -33.55% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.20 | 1.52 | 1.15 | 0.96 | 1.40 | 1.72 | 1.53 | 1.89 | 1.44 | 1.28 | 1.02 | 1.27 | |||||
| Quick Ratio | 0.99 | 1.21 | 0.75 | 0.73 | 0.74 | 1.13 | 0.91 | 1.41 | 0.90 | 0.65 | 0.46 | 0.65 | |||||
| Working Capital | 2.24M | 6.19M | 1.86M | -872.00K | 4.37M | 8.68M | 5.90M | 8.20M | 6.12M | 4.99M | 487.00K | 6.94M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 3.08 | 1.73 | -6.97 | -5.31 | 34.37 | 3.99 | 2.35 | 0.98 | -4.88 | 4.83 | 31.86 | 4.14 | |||||
| Interest Coverage TTM | -23.61 | -25.11 | -47.35 | -60.59 | -21.72 | -8.39 | -8.29 | -7.70 | -11.59 | -38.96 | -83.96 | -98.53 | |||||
| Debt Ratio | 0.76 | 0.63 | 1.17 | 1.23 | 0.97 | 0.80 | 0.70 | 0.49 | 1.08 | 0.83 | 0.97 | 0.81 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 2.09 | 1.65 | 2.19 | 1.88 | 1.85 | 1.49 | 1.34 | 1.21 | 1.00 | 0.86 | 0.75 | 0.64 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.95 | -1.04 | -1.63 | -1.77 | -1.30 | -1.61 | -1.11 | -1.33 | -2.12 | -1.63 | -1.93 | -1.67 | |||||
| Free Cash Flow Per Share TTM | -0.80 | -1.31 | -1.11 | -1.01 | -1.26 | -0.95 | -1.58 | -1.87 | -2.26 | -2.01 | -1.78 | -2.08 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | 55.30% | 52.16% | 49.62% | 50.32% | 51.31% | 50.72% | - | - | |||||
| Operating Profit Margin TTM | -25.74% | -27.21% | -47.40% | -41.59% | -42.87% | -46.11% | -54.77% | -53.98% | -68.13% | -66.56% | -72.67% | -80.73% | |||||
| Net Profit Margin TTM | -25.66% | -25.26% | -47.28% | -42.34% | -30.33% | -47.58% | -36.31% | -38.34% | -69.44% | -59.09% | -78.65% | -78.03% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 13.70% | 11.75% | 5.11% | 11.20% | 14.28% | 9.54% | 5.16% | 21.32% | 20.23% | 18.82% | -12.21% | -24.18% | |||||
| Net Income Growth (1Y) | -3.82% | -40.67% | 36.89% | 22.81% | -50.09% | -11.78% | -51.45% | -40.40% | 68.80% | 3,045.47% | 35.21% | -31.32% | |||||
| EPS Growth (1Y) | -26.95% | -35.65% | 46.68% | 33.73% | -38.85% | -1.09% | -42.54% | -20.35% | 107.29% | 3,125.18% | 34.89% | -33.49% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.85 | -0.55 | -0.60 | -0.40 | -0.62 | -0.68 | -1.20 | -0.68 | -0.73 | -1.70 | -4.53 | -6.24 | |||||
| P/B TTM | 1.56 | 0.55 | -4.11 | -1.43 | 15.14 | 2.71 | 2.78 | 0.84 | -3.09 | 7.15 | 115.48 | 19.73 | |||||
| P/S TTM | 0.22 | 0.14 | 0.29 | 0.17 | 0.19 | 0.32 | 0.43 | 0.26 | 0.50 | 1.01 | 3.57 | 4.87 | |||||
| Market Cap | 9.45M | 5.80M | 10.62M | 6.66M | 7.10M | 12.03M | 15.36M | 9.14M | 16.74M | 34.27M | 119.87M | 141.52M | |||||
| Enterprise Value | 3.13M | -594.01K | 7.20M | -580.69K | 5.31M | 6.12M | 12.49M | 5.06M | 15.28M | 36.83M | 118.15M | 138.17M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -9.32M | -13.37M | -12.01M | -9.44M | -11.16M | -10.43M | -18.28M | -19.03M | -24.60M | -24.92M | -24.32M | -28.25M | |||||
| Net Debt | -6.32M | -6.39M | -3.42M | -7.24M | -1.79M | -5.91M | -2.87M | -4.08M | -1.46M | 2.56M | -1.73M | -3.35M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Biofrontera Inc. (BFRI) — SEC Financial Statements & Analysis
Biofrontera Inc. (BFRI) is a pharmaceutical preparations company, incorporated in DE. Biofrontera Inc. trades on BFRIW: Nasdaq as: BFRI: Nasdaq. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Biofrontera Inc. reported a 13.70% year-over-year revenue growth, a Gross Profit Margin of 55.30% (TTM), a Debt-to-Equity ratio of 3.08x, a Price-to-Sales (P/S) ratio of 0.22x (TTM), a Price-to-Book (P/B) ratio of 1.56 (TTM), at a market cap of $9.45M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 13.70%
- Gross Profit Margin TTM
- 55.30%
- Debt To Equity
- 3.08x
- P/S TTM
- 0.22x
- P/B TTM
- 1.56
- Market Cap
- $9.45M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Biofrontera Inc. in?
Biofrontera Inc. (BFRI) operates in the Pharmaceutical Preparations industry.
What is BFRI's market cap?
Biofrontera Inc. (BFRI) has a market capitalization of $9.45M as of 2026-03-31.
What exchange does BFRI trade on?
Biofrontera Inc. (BFRI) trades on the BFRIW: Nasdaq.
Where is Biofrontera Inc. incorporated?
Biofrontera Inc. is incorporated in DE.